2019 annual financial data
ADMA Biologics 2019 Net margin
ADMA Biologics 2019 net margin with verified reported values.
Direct answer
Net margin was -164.5%.
Operating income was -41,424,327 USD and net income was -48,279,317 USD.
Operating cash flow was -76,193,504 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,349,083 USD
- Operating income
- -41,424,327 USD
- Net income
- -48,279,317 USD
- Operating cash flow
- -76,193,504 USD